In Phase I studies, ZYIL1 was found to be safe and well-tolerated in human volunteers
With India supplying around 60% of the world's vaccine needs and 20-22% of generic exports, the country is dedicated to providing affordable, high-quality drugs and contribute to global accessibility
Combating the prevalent stigma against TB in the society, India has been committed to providing, enabling and patient-centric support to all, individuals suffering from TB
Combination creates an integrated provider of drug development and regulatory consulting services serving a complementary client base
Newcastle University’s Dr Srikanth Ramaswamy has been announced as one of six new Fellows selected for the 2023 Lister prize
LyondellBasell is among the top three global polyolefin manufacturers in terms of capacity and sustainable solutions
Teva will leverage Honeywell’s ‘Energy as a Service’ (EaaS) model
Preclina is renowned for its highly specialized services in autoimmune and inflammatory disorders
Subscribe To Our Newsletter & Stay Updated